Results 251 to 260 of about 73,061 (282)
Some of the next articles are maybe not open access.
Tubercle, 1965
Summary A convenient technique is described for distinguishing between Myco. tuberculosis and other mycobacteria by the biological assay of niacin produced in subculture. Results are usually obtained in eight days. The method dispenses with the need for cyanogen bromide and enables results to be obtained with dysgonic strains.
openaire +3 more sources
Summary A convenient technique is described for distinguishing between Myco. tuberculosis and other mycobacteria by the biological assay of niacin produced in subculture. Results are usually obtained in eight days. The method dispenses with the need for cyanogen bromide and enables results to be obtained with dysgonic strains.
openaire +3 more sources
Adipokines and treatment with niacin
Metabolism, 2006Adipokines may serve as an important etiologic link between atherosclerosis and obesity. Because adipose tissue is one site of action of the lipid-lowering drug niacin, we investigated whether niacin treatment would affect not only lipids but also adipokines. Twenty-four patients were treated with extended-release niacin.
Ruma Makarova +4 more
openaire +3 more sources
No effect of maternal niacin defficiency on niacin metabolism in newborn brain [PDF]
Neurochemical Research, 1981 The effects of maternal niacin and tryptophan deficiency on: (1) total niacin levels and (2) niacinamide entry into brain, blood, and liver of newborn rabbits were studied. The deficient maternal diet produced a decreased concentration of the oxidized niacinamide-containing vitamers in the liver (73% of controls; P less than 0.05) but not in the brain ...
Reynold Spector, Sheryl Huntoon
openaire +2 more sources
The American Journal of Cardiology, 2008
Nicotinic acid (niacin) has long been used for the treatment of lipid disorders and cardiovascular disease. Niacin favorably affects apolipoprotein (apo) B-containing lipoproteins (eg, very-low-density lipoprotein [VLDL], low-density lipoprotein [LDL], lipoprotein[a]) and increases apo A-I-containing lipoproteins (high-density lipoprotein [HDL ...
Moti L. Kashyap, Vaijinath S. Kamanna
openaire +3 more sources
Nicotinic acid (niacin) has long been used for the treatment of lipid disorders and cardiovascular disease. Niacin favorably affects apolipoprotein (apo) B-containing lipoproteins (eg, very-low-density lipoprotein [VLDL], low-density lipoprotein [LDL], lipoprotein[a]) and increases apo A-I-containing lipoproteins (high-density lipoprotein [HDL ...
Moti L. Kashyap, Vaijinath S. Kamanna
openaire +3 more sources
The American Journal of Cardiology, 1994
Abstract Treating hypercholesterolemia is effective both for the prevention and regression of coronary artery disease. 1–3 Lipid-lowering agents are being used more frequently and practitioners are therefore more likely to encounter the unusual side effects of these drugs.
Robert A. Phillips +3 more
openaire +3 more sources
Abstract Treating hypercholesterolemia is effective both for the prevention and regression of coronary artery disease. 1–3 Lipid-lowering agents are being used more frequently and practitioners are therefore more likely to encounter the unusual side effects of these drugs.
Robert A. Phillips +3 more
openaire +3 more sources
Niacin-tryptophan relationships for evaluating niacin equivalents [PDF]
The American Journal of Clinical Nutrition, 1981 L M Henderson +2 more
openaire +2 more sources
Niacin as antidyslipidemic drug
Canadian Journal of Physiology and Pharmacology, 2015Niacin is an important vitamin (B3) that can be used in gram doses to positively modify pathogenetically relevant lipid disorders: elevated LDL cholesterol, elevated non-HDL cholesterol, elevated triglycerides, elevated lipoprotein(a), and reduced HDL cholesterol.
openaire +3 more sources
JAMA: The Journal of the American Medical Association, 1969
To the Editor:— I would like to clarify an allusion about a relationship between suicide and patients with schizophrenia given niacin therapy, which Dr. Hoffer made in his reply to Drs. Henninger and Bowers ( 207 : 1355, 1969). Dr. Hoffer says that "none of 450 patients receiving niacin against 12 out of 450 receiving tranquilizers, electric ...
openaire +3 more sources
To the Editor:— I would like to clarify an allusion about a relationship between suicide and patients with schizophrenia given niacin therapy, which Dr. Hoffer made in his reply to Drs. Henninger and Bowers ( 207 : 1355, 1969). Dr. Hoffer says that "none of 450 patients receiving niacin against 12 out of 450 receiving tranquilizers, electric ...
openaire +3 more sources
Archives of Disease in Childhood, 2017
It’s rare for a single paper to claim to have not only discovered a new mechanism for disease but also a means of preventing it. A paper from Sydney, Australia, which at first sight appears somewhat obscure and theoretical, does just that (Shi H et al. NEJM 2017. doi: 10.1056/NEJMoa1616361). It combines genetic studies on four families with mouse model
openaire +3 more sources
It’s rare for a single paper to claim to have not only discovered a new mechanism for disease but also a means of preventing it. A paper from Sydney, Australia, which at first sight appears somewhat obscure and theoretical, does just that (Shi H et al. NEJM 2017. doi: 10.1056/NEJMoa1616361). It combines genetic studies on four families with mouse model
openaire +3 more sources